EUVIMEDAtrasti EUVIMED
Open access · CC BY-NC 4.0

Results of patch testing with five fragrance materials hitherto not tested: A dose‐finding study in the clinical population

Thanisorn Sukakul iD, Wolfgang Uter iD, Margarida Gonçalo iD, Joseph Huggard, Suzana Ljubojević Hadžavdić iD, Marie L A Schuttelaar iD, Cecilia Svedman iD, Matthias Vey, Marléne Isaksson iD, Bo Niklasson, Thomas Rustemeyer iD, Magnus Bruze iD

Contact Dermatitis · 2024

DOI: 10.1111/cod.14525 ↗

At a glance

Journal article in Contact Dermatitis, 2024. Written by Thanisorn Sukakul and 11 co-authors. Institution: Department of Occupational and Environmental Dermatology, Faculty of Medicine, Lund University, Malmö, Sweden. Major MEDLINE topics: Patch Tests, Dermatitis, Allergic Contact, Perfume, Allergens. Cited 5 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: IFRA, the International Fragrance Association.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background

Quantitative risk assessment (QRA) for skin sensitization is used to derive safe use levels of sensitising fragrance ingredients in products. Post‐marketing surveillance of the prevalence of contact allergy to these ingredients provides relevant data to help evaluate the performance of these measures.

Objectives

To determine a suitable patch test concentration for five fragrance materials that had hitherto not been tested on a regular basis. These concentrations are then to be used in a surveillance study with patch testing consecutive patients over an extended monitoring period. Materials and Methods Furaneol, CAS.3658‐77‐3; trans‐2‐hexenal, CAS.6728‐26‐3; 4,8‐dimethyl‐4,9‐decadienal, CAS.71077‐31‐1; longifolene, CAS.475‐20‐7; benzaldehyde, CAS.10052‐7, were patch tested with other fragrance allergens in four clinics. Patch testing was conducted in three rounds, starting with the lowest concentrations of the five ingredients. The doses were increased in the subsequent rounds if no late‐appearing positive reactions and virtually no irritant reactions were reported.

Results

Overall, 373 patients were tested. No positive allergic reaction was reported to the five ingredients. Patch test results of other fragrance allergens are reported.

Conclusions

The highest test concentrations are each considered safe for patch testing consecutive patients. Further surveillance based on these preparations will evaluate the hypothesis that QRA‐driven consumer product levels of these fragrances can prevent sensitization.

Subjects

MeSH terms (MEDLINE)

Patch TestsDermatitis, Allergic ContactPerfumeAllergensHumansFemaleMaleAdultMiddle AgedAgedRisk AssessmentYoung AdultAdolescentProduct Surveillance, Postmarketing

Author keywords

4,8‐dimethyl‐4,9‐decadienal (CAS 71077‐31‐1)allergic contact dermatitisbenzaldehyde (CAS 100–52‐7)fragrance contact allergyfuraneol (CAS 3658‐77‐3)longifolene (CAS 475–20‐7)quantitative risk assessmentskin sensitizationtrans‐2‐hexenal (CAS 6728‐26‐3)

Substances

PerfumeAllergens

Authors and institutions

  • Department of Occupational and Environmental Dermatology, Faculty of Medicine, Lund University, Malmö, Sweden.
  • Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen/Nürnberg, Erlangen, Germany.
  • Department of Dermatology, Coimbra University Hospital and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • The Huggard Consulting Group, S.A.R.L., Itzig, Luxembourg.
  • IFRA VP Scientific Affairs and IDEA Management Team, Brussels, Belgium.
  • Department of Dermatology and Venereology, School of Medicine University of Zagreb, University Hospital Center Zagreb, Zagreb, Croatia.

ORCID profiles: Thanisorn Sukakul, Wolfgang Uter, Margarida Gonçalo, Suzana Ljubojević Hadžavdić, Marie L A Schuttelaar, Cecilia Svedman, Marléne Isaksson, Thomas Rustemeyer, Magnus Bruze

Funding

  • IFRA, the International Fragrance Association

Cite

APA

Sukakul, T., Uter, W., Gonçalo, M., Huggard, J., Ljubojević Hadžavdić, S., Schuttelaar, M. L. A., Svedman, C., Vey, M., Isaksson, M., Niklasson, B., Rustemeyer, T., & Bruze, M. (2024). Results of patch testing with five fragrance materials hitherto not tested: A dose‐finding study in the clinical population. Contact Dermatitis. https://doi.org/10.1111/cod.14525

Vancouver

Sukakul T, Uter W, Gonçalo M, Huggard J, Ljubojević Hadžavdić S, Schuttelaar MLA, et al. Results of patch testing with five fragrance materials hitherto not tested: A dose‐finding study in the clinical population. Contact Dermatitis. 2024. doi:10.1111/cod.14525

BibTeX
@article{Sukakul2024,
  author = {Sukakul, Thanisorn and Uter, Wolfgang and Gonçalo, Margarida and Huggard, Joseph and Ljubojević Hadžavdić, Suzana and Schuttelaar, Marie L A and Svedman, Cecilia and Vey, Matthias and Isaksson, Marléne and Niklasson, Bo and Rustemeyer, Thomas and Bruze, Magnus},
  title = {Results of patch testing with five fragrance materials hitherto not tested: A dose‐finding study in the clinical population},
  journal = {Contact Dermatitis},
  year = {2024},
  doi = {10.1111/cod.14525}
}
Start for free →